Business
Australia to consider EU and UK findings over AstraZeneca Covid vaccine and blood clots – The Guardian
Review follows a UK decision to offer people under 30 an alternative jab following formal link to rare blood clots
Vaccines and immunisation
Australian authorities will review the findings of British and European regulators over concerns about the AstraZeneca Covid-19 vaccine but continue to emphasise that the benefits outweigh the risks.
The review follows a decision in the United Kingdom to offer healthy adults aged under 30 an alternative to the Oxford/AstraZeneca jab following concerns over rare blood clots.
The European Medicines Agency also announced on Wednesday that the rare blood clots would be listed…
-
Business16 hours agoThink Nvidia stock is expensive? This chart might change your mind.
-
General23 hours agoFormer Ukrainian parliament speaker Andriy Parubiy murdered in Lviv
-
General22 hours agoIsabelle Kelly hospitalised with suspected broken jaw in Sydney Roosters’ NRLW win
-
Noosa News16 hours agoYoung rockers prepare to hit the stage in Eumundi